Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 893 of 5804
-
Lying a certain way after brain surgery may stop bleeds returning
Prevention Recruiting nowThis study aims to investigate the effectiveness and safety of body posture to improve intracranial pressure in preventing postoperative recurrence for chronic subdural hematoma
Phase: NA • Sponsor: Huashan Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:26 UTC
-
Radioactive antibody hunt: could a new scan outsmart hidden kidney cancer?
Diagnosis Recruiting nowThis phase II trial compares the safety and effectiveness of 89Zr-DFO-GmAb positron emission tomography (PET)/computed tomography (CT) compared to contrast-enhanced CT after surgery in detecting clear cell renal cell cancer that has come back (recurrent). For some patients, the r…
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Umbilical cord stem cells aim to slow muscle loss in duchenne boys
Disease control OngoingThe primary objective of this study is to provide UC-MSC treatment to patients with DMD. Secondary objectives will be to further evaluate treatment-related adverse events as well as changes in DMD-related functional testing/assessments, blood laboratories, and inflammation relat…
Phase: PHASE2 • Sponsor: MED Institute Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a smaller surgery beat lung cancer after chemo?
Disease control Recruiting nowThe primary objective will be to determine the feasibility of performing a high-quality sublobar anatomic resection (segmentectomy) with R0 margin status on final pathology for patients who received induction therapy for NSCLC and are downstaged to ≤ycT1cN0M0 (TDi 3cm or less). T…
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Mind-Controlled glove could help stroke survivors move their hands again
Disease control Recruiting nowUpper extremity (UE) recovery remains a huge rehabilitation challenge with largely incomplete recovery of the upper limb post stroke. This is due to heavier priorities placed on other stroke competencies such as mobility, activities of daily living training and home integration w…
Phase: NA • Sponsor: Tan Tock Seng Hospital • Aim: Disease control
Last updated Jun 26, 2026 15:00 UTC
-
DNA test could revolutionize treatment for Drug-Resistant TB
Diagnosis Recruiting nowTS ELiOT is a stepped-wedge, cluster randomized trial assessing the effect of a next-generation sequencing-based strategy on rifampin-resistant tuberculosis management and patient outcomes.
Phase: NA • Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 08:14 UTC
-
New hope for breast cancer patients: drug may tame hot flashes without hormones
Symptom relief OngoingOne of the standard treatments for women with breast cancer is hormone therapy, but this treatment can cause hot flashes. Hormone replacement therapy, or HRT, is most often prescribed for hot flashes for women in menopause but cannot be given to women on hormone therapy for breas…
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Growth hormone may cut IV feeding needs for short bowel patients
Disease control Recruiting nowThis is a multicenter, open-label, single-arm clinical trial. A total of 100 participants with short bowel syndrome (SBS) receiving parenteral nutrition (PN) support are planned to be enrolled. The trial includes a 2-week run-in phase and a 4-week intervention phase, during which…
Phase: PHASE4 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Spiritual healing for veterans: new therapy targets moral injury
Disease control ENROLLING_BY_INVITATIONMoral Injury Syndrome (MIS) affects up to 35-60% of Veterans managing combat-related PTSD; it results from experiences that challenge deeply held values or spiritual beliefs. Symptoms of MIS may include hopelessness, helplessness, loss of spiritual beliefs, difficulty with forgiv…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
AI and mindfulness join forces to tackle chronic back pain
Symptom relief Recruiting nowThis study will identify unique signatures that people have which can cause pain by evaluating biological, psychological, and social markers using artificial intelligence. These markers can be used to accurately predict the response of diverse individuals with chronic low back pa…
Phase: NA • Sponsor: Boston Medical Center • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New pill aims to slow rare brain disease in landmark trial
Disease control OngoingPROSPER trial is a trial to assess the efficacy of FNP-223 in slowing disease progression in participants with PSP as measured by the PSP Rating Scale (PSPRS) over 52 weeks and to assess the safety and tolerability of FNP-223 for 52 weeks in participants with PSP.
Phase: PHASE2 • Sponsor: Ferrer Internacional S.A. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug plozasiran aims to tame dangerous fat levels in blood
Disease control OngoingThis Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (SHTG). After providing informed consent eligible participants will be randomized to receive 4 doses (once every 3 months) of plozas…
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug aims to calm relentless itch of prurigo nodularis
Symptom relief OngoingThe main objective of the study will be to evaluate the efficacy of rocatinlimab compared with placebo at week 24 on the patient-reported outcome (PRO) measure of pruritus and overall clinical assessment score (US only).
Phase: PHASE3 • Sponsor: Amgen • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Can tailored rehab help long COVID patients get moving again?
Symptom relief CompletedThis is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key …
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New blood recycling method may cut bleeding in High-Risk heart surgery
Disease control Recruiting nowDespite significant advances in patient blood management, cardiac surgery remains a surgical procedure at high risk for bleeding. Numerous perioperative blood conservation strategies have been developed for limiting the use of blood products. Among them, the processing of shed bl…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Double drug attack: new hope for tough Crohn's cases?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of dual-target therapy (Ustekinumab combined with Upadacitinib) versus intensified Ustekinumab monotherapy in patients with Crohn's disease who have an inadequate response to standard doses of Ustekinumab. The…
Phase: PHASE4 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Sound waves to the rescue: new device aims to heal legs and prevent amputation
Disease control Recruiting nowCALCIO is a multicentre, prospective, observational cohort study that will collect real world data on the use of intravascular Lithotripsy (IVL) with the Shockwave IVL system to disrupt calcified femoropopliteal and crural lesions in patients with chronic limb-threatening ischemi…
Sponsor: Cardiovascular and Interventional Radiological Society of Europe • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New portable pump could let fistula patients ditch IV nutrition at home
Disease control Recruiting nowHigh-output enterocutaneous fistulas (HOF) and double enterostomies are severe complications of abdominal surgery or trauma. Double enterostomies are typically created after small bowel resection in fragile patients who cannot tolerate intestinal reconnection. Reconnection is gen…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Intermittent dieting may reverse early heart risks in kids
Disease control Recruiting nowThis randomized trial aims to evaluate the health-promoting effects of intermittent dietary restrictions, including intermittent low-carbohydrate diet (ILCD) and calorie restriction (ICR), in school-aged children with cardiometabolic risk (CMR) compared with general health educat…
Phase: NA • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
E-Cigarettes vs. medication: a new hope for stubborn smokers?
Disease control Recruiting nowThis study evaluates whether non-cigarette tobacco products (e-cigarettes) can help smokers quit smoking as compared to traditional quit methods (nicotine replacement therapy or varenicline/Chantix). Participants in this study will be randomly assigned to one of two groups, then …
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC